Test bank For Pharmacology For Nurses A Pathophysiologic Approach 5th Edition by Michael Patrick Adams

Test Bank For Pharmacology For Nurses A Pathophysiologic Approach 5th Edition By Michael Patrick Adams is an essential study guide for any nursing student enrolled in a pharmacology course. The book covers all of the major drug classifications and their mechanism of action, along with a detailed discussion of how each drug interacts with the body. In addition, the Test Bank provides a comprehensive review of pharmacology for the NCLEX-RN exam.

The Test Bank includes over 2,000 questions, divided into four sections: General Principles, Cardiovascular, Respiratory, and Gastrointestinal. With its comprehensive coverage and practice questions, the Test Bank is an invaluable resource for any nursing student preparing for the pharmacology section of the NCLEX-RN exam.

Digital item No Waiting Time Instant Download
ISBN 10: 013425516X ISBN-13: 9780134255163

In Stock

Original price was: $65.00.Current price is: $40.00.

Compare
SKU:000786000199

Test bank For Pharmacology For Nurses A Pathophysiologic Approach 5th Edition by Michael Patrick Adams

Adams, Pharmacology for Nurses: A Pathophysiologic Approach, 5/E
Chapter 2

Question:1

Type: MCSA

The pharmaceutical representative comes to the physician’s office and says his company’s pharmaceutical laboratory is marketing a drug that does not need approval by the Food and Drug Administration (FDA). What is the best response by the nurse?

1. “Any pharmaceutical laboratory in America must have approval from the Food and Drug Administration (FDA) before marketing a drug.”

2. “Is this an over-the-counter (OTC) drug? They do not need approval by the Food and Drug Administration (FDA).”

3. “Is your pharmaceutical laboratory private? Only public pharmaceutical laboratories need approval from the Food and Drug Administration (FDA).”

4. “Your pharmaceutical laboratory must be involved in academic research because they are exempt from approval by the Food and Drug Administration (FDA).”

Correct Answer: 1

Rationale 1: Any pharmaceutical laboratory must obtain approval from the Food and Drug Administration (FDA) before marketing a drug. 

Rationale 2: Pharmaceutical laboratories that manufacture over-the-counter (OTC) drugs must obtain approval from the Food and Drug Administration (FDA) before marketing these drugs.

Rationale 3: Private pharmaceutical laboratories must obtain approval from the Food and Drug Administration (FDA) before marketing a drug. 

Rationale 4: Pharmaceutical laboratories involved in academic research must obtain approval from the Food and Drug Administration (FDA) before marketing a drug. 

Global Rationale: Any pharmaceutical laboratory, whether private, public, or academic, must obtain approval from the Food and Drug Administration (FDA) before marketing a drug. Private pharmaceutical laboratories must obtain approval from the Food and Drug Administration (FDA) before marketing a drug. Pharmaceutical laboratories involved in academic research must obtain approval from the Food and Drug Administration (FDA) before marketing a drug. Pharmaceutical laboratories that manufacture over-the-counter (OTC) drugs must obtain approval from the Food and Drug Administration (FDA) before marketing these drugs.

Cognitive Level: Applying

Client Need: Physiological Integrity

Client Need Sub: Pharmacological and Parenteral Therapies

QSEN Competencies: V.B.1 Demonstrate effective use of technology and standardized practices that support safety and quality.

AACN Essential Competencies: V.4 Examine legislative and regulatory processes relevant to the provision of health care. 

NLN Competencies: Quality and Safety: Policies and procedures.

Nursing/Integrated Concepts: Nursing Process: Implementation

Learning Outcome: 2-2 Discuss the role of the U.S. Food and Drug Administration (FDA) in the drug approval process.

MNL Learning Outcome: 1.1.1 Apply basic concepts related to pharmacology.

Page Number: 13

Question 2

Type: MCSA

The nurse is employed by the Food and Drug Administration (FDA) and is involved in clinical investigation. What is the primary role of the nurse in this phase of the review and approval process by the FDA?

1. To perform tests on the population-at-large

2. To perform tests on various species of animals

3. To perform tests on human cells cultured in the laboratory

4. To perform tests on human clients

Correct Answer: 4

Rationale 1: Performing tests on the population-at-large is the stage of post-marketing surveillance. 

Rationale 2: Performing tests on various species of animals is the preclinical investigation stage.

Rationale 3: Performing tests on human cells cultured in the laboratory is the preclinical investigation stage.

Rationale 4: Clinical investigation includes performing tests on healthy volunteers, and later, on selected clients with a particular disease. 

Global Rationale: Clinical investigation includes performing tests on healthy volunteers, and later, on selected clients with a particular disease. Performing tests on human cells cultured in the laboratory is the preclinical investigation stage. Performing tests on the population-at-large is the stage of post-marketing surveillance. Performing tests on various species of animals is the preclinical investigation stage.

Cognitive Level: Applying

Client Need: Physiological Integrity

Client Need Sub: Pharmacological and Parenteral Therapies

QSEN Competencies: V.B.1 Demonstrate effective use of technology and standardized practices that support safety and quality.

AACN Essential Competencies: V.4 Examine legislative and regulatory processes relevant to the provision of health care. 

NLN Competencies: Quality and Safety: Policies and procedures.

Nursing/Integrated Concepts: Nursing Process: Implementation

Learning Outcome: 2-5 Identify the nurse’s role in the drug approval process and in maintaining safety practices.

MNL Learning Outcome: 1.1.1 Apply basic concepts related to pharmacology.

Page Number: 13

Question 3

Type: MCSA

The student nurse is taking a pharmacology course and studying about the Food and Drug Administration (FDA). What has the student learned about how the FDA has decreased the amount of time involved in bringing a new drug to the market?

1. The Food and Drug Administration (FDA) is not as strict as it once was with regard to drug approval.

2. Since consumers have demanded more drugs, the Food and Drug Administration (FDA) has streamlined the review/approval process.

3. Drug manufacturers are required to pay yearly user fees, which allow the Food and Drug Administration (FDA) to hire more employees to increase its efficiency.

4. Drug manufacturers are required by the Food and Drug Administration (FDA) to test more drugs on an annual basis.

Correct Answer: 3

Rationale 1: The Food and Drug Administration (FDA) is just as strict now as it always was with regard to drug approval. 

Rationale 2: The Food and Drug Administration (FDA) has not streamlined the review/approval process. 

Rationale 3: In 1992, the Prescription Drug User Fee Act was passed. This required drug manufacturers to provide yearly product user fees so the Food and Drug Administration (FDA) could restructure, hire more employees, and operate more efficiently. 

Rationale 4: The Food and Drug Administration (FDA) does not require drug manufacturers to test more drugs on an annual basis.

Global Rationale: In 1992, the Prescription Drug User Fee Act was passed. This required drug manufacturers to provide yearly product user fees so the Food and Drug Administration (FDA) could restructure, hire more employees, and operate more efficiently. The Food and Drug Administration (FDA) is just as strict now as it always was with regard to drug approval. The Food and Drug Administration (FDA) has not streamlined the review/approval process. The Food and Drug Administration (FDA) does not require drug manufacturers to test more drugs on an annual basis.

Cognitive Level: Applying

Client Need: Physiological Integrity

Client Need Sub: Pharmacological and Parenteral Therapies

QSEN Competencies: V.B.1 Demonstrate effective use of technology and standardized practices that support safety and quality.

AACN Essential Competencies: V.4 Examine legislative and regulatory processes relevant to the provision of health care. 

NLN Competencies: Quality and Safety: Policies and procedures.

Nursing/Integrated Concepts: Nursing Process: Implementation

Learning Outcome: 2-4 Discuss how the FDA has increased the speed with which new drugs reach consumers.

MNL Learning Outcome: 1.1.1 Apply basic concepts related to pharmacology.

Page Number: 15

Question 4

Type: MCSA

The client has skin lesions that have not responded to prescription drugs. He tells the nurse he has heard about some research going on with a new drug and questions why he can’t take it. What is the best response by the nurse?

1. “I know it is frustrating, but the Food and Drug Administration (FDA) approval process is in place to ensure that drugs are safe.”

2. “The Food and Drug Administration (FDA) has very strict rules about new drugs; it is important to be patient regarding the review/approval process.”

3. “Your skin lesions really aren’t that bad, but maybe the new drug will be available soon.”

4. “Maybe you could contact the drug company about becoming involved in a clinical trial.”

Correct Answer: 1

Rationale 1: Although the public is anxious to receive new drugs, the fundamental priority of the Food and Drug Administration (FDA) is to ensure that drugs are safe. Also, telling the client that the nurse knows he is frustrated is therapeutic because it communicates that the nurse recognizes what he is feeling. 

Rationale 2: Telling the client to be patient is a condescending response; the client wants relief from the skin condition.

Rationale 3: Telling the client his skin lesions “aren’t that bad” is a non-therapeutic response; the client’s perception is his reality. 

Rationale 4: The client could contact the drug company, but this response fosters false hope as he may not be a viable candidate for this drug. 

Global Rationale: Although the public is anxious to receive new drugs, the fundamental priority of the Food and Drug Administration (FDA) is to ensure that drugs are safe. Also, telling the client that the nurse knows he is frustrated is therapeutic because it communicates that the nurse recognizes what he is feeling. The client could contact the drug company, but this response fosters false hope as he may not be a viable candidate for this drug. Telling the client his skin lesions “aren’t that bad” is a non-therapeutic response; the client’s perception is his reality. Telling the client to be patient is a condescending response; the client wants relief from the skin condition.

Cognitive Level: Applying

Client Need: Physiological Integrity

Client Need Sub: Pharmacological and Parenteral Therapies

QSEN Competencies: V.B.1 Demonstrate effective use of technology and standardized practices that support safety and quality.

AACN Essential Competencies: V.4 Examine legislative and regulatory processes relevant to the provision of health care. 

NLN Competencies: Quality and Safety: Policies and procedures.

Nursing/Integrated Concepts: Nursing Process: Implementation

Learning Outcome: 2-2 Discuss the role of the U.S. Food and Drug Administration (FDA) in the drug approval process.

MNL Learning Outcome: 1.1.1 Apply basic concepts related to pharmacology.

Page Number: 13

Question 5

Type: MCSA

What percentage of Americans takes at least one prescription drug per year?

1. 50%

2. 10%

3. 40%

4. 25%

Correct Answer: 1

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Pharmacology And The Nursing Process 9th Edition Lilley Test Bank

Original price was: $80.00.Current price is: $14.50.
(0 Reviews)
Pharmacology And The Nursing Process 9th Edition Lilley Test Bank is a great resource for nurses. It provides a comprehensive overview of pharmacology and the nursing process. The book is divided into four parts: Pharmacokinetics, Pharmacodynamics, Pharmacotherapeutics, and Pharmacotherapy. Each section provides detailed information on the various drugs used to treat different conditions. In addition, the book includes a variety of practice questions and answers to ensure that nurses have a solid understanding of the material. Pharmacology And The Nursing Process 9th Edition Lilley Test Bank is an essential resource for any nurse looking to expand their knowledge of pharmacology. Digital item No Waiting Time Instant Download Chapters: 58 Format: PDF ISBN-13: 978-0323529495 ISBN-10: 0323529496 Publisher: Mosby Authors: Linda Lane Lilley, Shelly Rainforth Collins PharmD, Julie S. Snyder

Pharmacology: A Patient-Centered Nursing Process Approach 10th Edition Test Bank

Original price was: $55.00.Current price is: $17.00.
(0 Reviews)
Digital item No Waiting Time Instant Download Chapters: 55 Format: PDF ISBN-13: 978-0323642477 ISBN-10: 0323642470 Publisher: Saunders Authors: Linda E. McCuistion, Kathleen DiMaggio, Mary Beth Winton, Jennifer J. Yeager

Basic and Clinical Pharmacology 14th Edition Katzung Trevor Test Bank

Original price was: $55.00.Current price is: $23.00.
(0 Reviews)
Digital item No Waiting Time Instant Download Chapters: 66 Chapters: PDF ISBN-13: 978-1259641152 ISBN-10: 1259641155 Publisher: ‎MG. Hill Authors: Bertram Katzung

Pharmacotherapeutics for Advanced Practice: A Practical Approach 5th Edition Arcangelo Test Bank

Original price was: $55.00.Current price is: $28.00.
(0 Reviews)
Digital item No Waiting Time Instant Download Chapters: 56 Format: PDF ISBN-13: 978-1975160593 ISBN-10: 1975160592 Publisher: ‎LWW Authors: Virginia Poole Arcangelo, Andrew M. Peterson PharmD, Veronica Wilbur, Dr. Tep M. Kang PharmD

Focus on Nursing Pharmacology 8th Edition Test Bank

Original price was: $55.00.Current price is: $18.00.
(0 Reviews)
Digital item No Waiting Time Instant Download Format: PDF Chapters: 59 ISBN-13: 978-1975100964 ISBN-10: 1975100964. Publisher: ‎LWW; 8th edition Author: Amy M. Karch

Test bank For Pharmacology For Nurses A Pathophysiologic Approach 5th Edition by Michael Patrick Adams

Original price was: $65.00.Current price is: $40.00.
(0 Reviews)
Test Bank For Pharmacology For Nurses A Pathophysiologic Approach 5th Edition By Michael Patrick Adams is an essential study guide for any nursing student enrolled in a pharmacology course. The book covers all of the major drug classifications and their mechanism of action, along with a detailed discussion of how each drug interacts with the body. In addition, the Test Bank provides a comprehensive review of pharmacology for the NCLEX-RN exam. The Test Bank includes over 2,000 questions, divided into four sections: General Principles, Cardiovascular, Respiratory, and Gastrointestinal. With its comprehensive coverage and practice questions, the Test Bank is an invaluable resource for any nursing student preparing for the pharmacology section of the NCLEX-RN exam. Digital item No Waiting Time Instant Download ISBN 10: 013425516X ISBN-13: 9780134255163

Test Bank For Pharmacology For the Primary Care Provider 4th Edition by Edmunds Mayhew

Original price was: $85.00.Current price is: $45.00.
(0 Reviews)
Test Bank for Pharmacology for the Primary Care Provider, 4th Edition by Edmunds Mayhew provides comprehensive coverage of pharmacology for primary care providers. The Test Bank includes questions on all major topics covered in the text, as well as a section on medical conditions and diseases. The Test Bank is an essential resource for students preparing for exams, and for instructors who want to create practice quizzes and tests. Test Bank For Pharmacology For The Primary Care Provider 4th Edition By Edmunds Mayhew is a valuable resource for students and instructors alike. Digital item No Waiting Time Instant Download ISBN-13: 978-0323087902 ISBN-10: 0323087906

 

 

Product has been added to your cart